ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018)
ENDRA Life Sciences (NDRA) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2018, down 97.19% YoY from 0.05 in Q4 2017, and down 75.85% sequentially from 0.01 in Q3 2018.
ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018) Analysis & Trends
ENDRA Life Sciences has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.0 for Q4 2018.
- In Q4 2018, Asset Utilization Ratio fell 97.19% year-over-year to 0.0; the TTM figure through Dec 2018 stood at 0.0 (down 97.19% YoY), while the FY2018 annual figure was 0.0, down 99.13% from the prior year.
- Asset Utilization Ratio slipped to 0.0 in Q4 2018, from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for NDRA reached as high as 0.14 in Q2 2017 and fell as low as 0.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 0.25 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 0.40 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 0.30 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 1.32 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 1.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 0.56 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 0.56 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 0.67 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 1.11 |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.09 |
| Mar 31, 2018 | 0.07 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.14 |